Stacy Lindborg - Sep 6, 2024 Form 4/A - Amendment Insider Report for Imunon, Inc. (IMNN)

Role
President and CEO, Director
Signature
/s/ Susan Eylward, Attorney-in-Fact for Stacy Lindborg
Stock symbol
IMNN
Transactions as of
Sep 6, 2024
Transactions value $
$0
Form type
4/A - Amendment
Date filed
10/31/2024, 07:57 PM
Date Of Original Report
Sep 10, 2024
Previous filing
Aug 16, 2024
Next filing
Sep 10, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMNN Restricted Stock Units Award $0 +25K $0.00 25K Sep 6, 2024 Common Stock 25K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This amendment reports a new transaction that was inadvertently omitted from the Form 4 filed on September 10, 2024 by the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of Imunon, Inc.'s common stock.
F2 On September 6, 2024, Ms. Lindborg received restricted stock units representing 25,000 shares subject to a one-year vesting schedule, vesting 100% on the first anniversary of the grant date. As restricted stock units vest, the vested units are automatically converted to vested common stock on a one-for-one basis on the vesting date.